μL/min to 18 mL of refolding buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 5% (v/v) glycerol, 5% (w/v) sucrose and 400 mM L-arginine) under continuous stirring. The refolding mixture was filtered through a 0.45 μm filter and loaded onto a Ni-NTA Sepharose column (42 mm H x 5 mm ID) previously equilibrated with 50 mM Tris-HCl, pH 8.0 and 500 mM NaCl at a flow rate of 0.4 mL/min. The protein was eluted between 125-210 mM imidazole in a gradient of 0 to 500 mM imidazole in 50 mM Tris-HCl, pH 8 were identified by database searching of the fragment spectra against the SwissProt (EBI) protein database using Mascot (v 2.6.2, Matrix Science, London, UK) through Proteome Discoverer (v 1.4, Thermo Scientific). Database search settings were: mass tolerances, 10 ppm precursor, 0.8d fragments; variable modifications, methionine sulfoxide, pyro-glutamate formation; Trypsin, up to 2 missed cleavages. FDR estimates were from Proteome Discoverer. All the identified peptides were above the MASCOT threshold score for identity with a p-value of <0.05. The analysis identified a total of 37 unique peptides (28 for full length ALK and 9 for full length NPM), with peptides ranging in length from 9 to 36 amino acid residues.
Cell lines. Karpas 299 (CD30+) and SU-DHL-1 4 human ALCL cell lines were obtained from Dr. Mark Raffeld at the National Cancer Institute/National Institutes of Health. Jurkat T-cell, CA46 B-cell and U937 histiocytic human lymphoma cell lines negative for both full-length wild type ALK and NPM-ALK fusion proteins were purchased from American Type Culture Collection (ATCC; Manassas, VA). IMR-32 human neuroblastoma cell line, negative for the NPM-ALK fusion protein but positive for full-length wild type ALK protein [5] [6] [7] , was also purchased from American Type Culture Collection (ATCC; Manassas, VA). All cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 unit /mL penicillin and 100 µg/mL streptomycin at 37 °C in a humidified atmosphere with 5% CO2. After two days' culture, cells were harvested and viable cells were counted using trypan blue stain. After washing twice in PBS, cells were centrifuged, resuspended in RPMI 1640 medium with 10% DMSO and stored at -80 °C (1.5 to 5 x10 6 cells/per vial) for later use.
Frozen cells were thawed in a pre-warmed water bath at 37 °C for 10 min, transferred to clean Eppendorf tubes and centrifuged at 500 xg for 10 min at 4 °C. Cell pellets were washed in 1 mL PBS, and centrifuged at 500 xg for 10 min at 4 °C. After removal of the supernatant, cells were resuspended in the non-denaturing cell lysis buffer (#9803; Cell Signaling Technology, Inc.; chosen after screening of 3 lysis reagents; see Figure 2 , main text) and incubated on ice for 5 min according to the manufacturer's instructions. Thereafter, the lysates were centrifuged at 14,000 xg for 10 min at 4 °C to remove cell debris, the supernatant transferred to new vials and total protein quantified by BCA assay with bovine serum albumin (BSA) as a standard.
Optimized ELISA. The wells of a Nunc ® MicroWell™ 96 well polystyrene plate were coated with 100 μL of 2.5 μg/mL anti-NPM-ALK capture antibody (ab180607; Abcam) diluted in PBS, pH 7.5 and the plate was incubated at 4 °C overnight. The antibody solution was removed and the wells were passivated with 300 μL PBS/3% BSA for 1 h at 37 °C. The wells were then washed three times with PBS/0.1% TWEEN ® 20. Samples (100 µL) were then added to each well, and the plate was incubated for 1.5 h at 37 °C. Then the wells were emptied and washed three times with PBS/0.1% TWEEN ® 20. Detection antibodies (#3791; anti-ALK mouse monoclonal antibody; Cell Signaling Technologies; 100 μL, 0.5 μg/mL in PBS/0.1% BSA) were added to each well, and the plate was incubated for 30 min at 37 °C. Supernatant was removed and the wells were washed three times with PBS/0.1% TWEEN ® 20. Anti-mouse IgG horseradish peroxidase conjugates (100 µL/well; used at 1000-fold dilution of the stock in PBS/0.1% BSA) were added and the plate was incubated for 30 min at 37 °C. Supernatant was removed, the wells were washed three times with PBS/0.1% TWEEN ® 20 and 100 µL 1-Step™ Ultra TMB-ELISA Substrate Solution was added to the wells. Following incubation for 20 min at 37 °C, 50 µL 2 M sulfuric acid was added to each well, and the absorbance at 450 nm was measured with an Infinite ® M200 PRO multimode reader. All washing steps were performed on a Tecan HydroFlex microplate washer using a typical wash program (3 cycles, Normal Mode, Aspirate Time 1 sec, Aspirate rate 2, Head Speed 10 mm/sec; zposition: overflow, Dispense Volume 400 μL/well, Dispense Rate 300 μL/sec). For the first-dimension electrophoresis, isoelectric focusing was carried out using the GE Healthcare IPGphor II pH 3-10 nonlinear, 24-cm immobilized pH gradient (IPG) strips (GE Healthcare) overnight. Subsequently, the IPG strips were loaded onto 8-18% SDS-PAGE gels (24x20 cm) for the second-dimension electrophoresis. Postelectrophoresis, the gels were scanned in a Typhoon 9400 laser scanner (GE Healthcare) and digital images were recorded using ImageQuant (GE Healthcare) software. Individual protein spots observed in the image were then quantified and compared after volumetric rendering using the differential in-gel analysis (DIA) algorithm within DeCyder (v5.5; GE Healthcare) software. Finally, the spot of NPM-ALK protein on the second-dimension gel was cut out and peptide sequencing was performed in the Translational Proteomics Core at UTHealth, essentially as previously described 8 
Cellular protein analysis by two

